Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test
The company’s Preecludia™ test performed strongly in a broad, intended-use populationSAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc....